Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNanoco Regulatory News (NANO)

Share Price Information for Nanoco (NANO)

Share Price is delayed by 15 minutes
Get Live Data
2.70    0.11 (4.25%)
Bid:
2.55
Ask:
2.69
Spread: 0.14 (5.49%)
Market Cap: £4.93m
NANO Live PriceLast checked at - London Stock Exchange

Intraday Nanoco Share Chart

AGM Statement

10 Dec 2015 07:00

RNS Number : 6113I
Nanoco Group PLC
10 December 2015
 



For immediate release

10 December 2015

 

 

 

NANOCO GROUP PLC

("Nanoco" or the "Company")

 

AGM Statement

 

Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other nanomaterials, will this morning hold its Annual General Meeting ("AGM") at its headquarters in Manchester.

 

Anthony Clinch, Nanoco's Chairman, will make the following statement:

 

"We are very pleased with the progress made to date in the commercialisation of our technology in our chosen target markets.

 

"Michael Edelman, our CEO, has just returned from Asia, during which time he visited the Cheonan manufacturing plant. He was hugely impressed by what Dow has achieved at the plant, which is producing high quality, cadmium-free quantum dot batches to the required specification. Dow's success in demonstrating the scalability of Nanoco's technology is a major milestone for us.

 

"The transfer to South Korea of the production of cadmium free quantum dots, which we previously expected to be performed in Runcorn, is being accelerated. As a result, we now expect the plant to be ready to supply material to meet potential customers' commercial requirements within the first quarter of calendar year 2016. Currently, they are being sampled with film that uses quantum dots produced in Nanoco's Runcorn production facility.

 

 "Dr Edelman met with Dow's potential customers and we remain convinced of the huge commercial opportunity open to the Company in the display market.

 

"Nanoco's Lighting Division, which was formed earlier this year, is making significant progress including the launch of four LED-based product groups at the recent LuxLive trade show in London. These lighting products, created with our partner Marl International, use Nanoco CFQD® Quantum Dot film and were very well received at the show. In addition, the Lighting Division is developing a phototherapy product for the cosmetic treatment of skin, which is progressing well.

 

"Nanoco continues to benefit from a strong balance sheet to support the commercialisation of its technology, continued product development and research. We believe that 2016 will be a landmark year in the Company's development."

 

 

 

For further information, please contact:

 

Nanoco

Tel: +44 (0) 161 603 7900

Michael Edelman, Chief Executive Officer

David Blain, Chief Financial Officer

Caroline Watson, Investor Relations Manager

cwatson@nanocotechnologies.com

 

Tel: + 44 (0) 7799 897357

Canaccord Genuity - Joint Broker

Tel: +44 (0) 20 7523 8000

Simon Bridges

Cameron Duncan

Mark Whitmore

Liberum - Joint Broker

Tel: +44 (0) 20 3100 2000

Neil Patel

Richard Bootle

Steven Tredget

Buchanan

Tel: +44 (0) 20 7466 5000

Mark Court / Sophie Cowles / Stephanie Watson

 

 

Notes for editors:

 

About Nanoco Group plc

Nanoco is a world leader in the development and production of cadmium-free quantum dots and other nano-materials for use in multiple applications including LCD displays, lighting, solar cells and bio-imaging. In the display market, it has an exclusive manufacturing and marketing licensing agreement with The Dow Chemical Company.

 

Nanoco was founded in 2001 and is headquartered in Manchester, UK. It has production facilities in Runcorn, UK, and a US subsidiary, Nanoco Inc, based in Concord, MA. Nanoco also has business development executives in Japan, Korea and Taiwan. Its technology is protected worldwide by a large and growing patent estate.

 

Nanoco is listed on the main market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit: www.nanocogroup.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMEAKAEFLESFEF
Date   Source Headline
12th Jul 20247:00 amRNSHolding(s) in Company
11th Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
10th Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
8th Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
5th Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
4th Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
3rd Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
2nd Jul 20247:01 amRNSTransaction in Own Shares and Total Voting Rights
2nd Jul 20247:00 amRNSYear End Trading Update
1st Jul 20247:00 amRNSTransaction in Own Shares
10th Jun 20247:00 amRNSBlocklisting Six Monthly Return
31st May 20245:19 pmRNSTotal Voting Rights and Share Capital
9th May 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
8th May 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
7th May 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
3rd May 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
2nd May 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
1st May 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
30th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
26th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
25th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
24th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
23rd Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
22nd Apr 20244:06 pmRNSTR-1: Notification of Major Holdings
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20243:02 pmRNSExercise of Deferred Bonus Options
18th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Apr 20241:56 pmRNSNotification of Major Holdings
17th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
16th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
15th Apr 20244:10 pmRNSDirector/PDMR Shareholding
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Apr 20247:00 amRNSResult of Tender Offer
28th Mar 202412:52 pmRNSGeneral Meeting - Voting Results
27th Mar 20247:00 amRNSInterim Results
11th Mar 202412:47 pmRNSPosting of Circular
11th Mar 20247:00 amRNSProposed return of up to £33.0 million
8th Feb 20247:00 amRNSHalf Year Trading Update
7th Feb 202411:23 amRNSDirector Declaration
24th Jan 20247:00 amRNSReceipt of Final Litigation Proceeds
23rd Jan 20244:02 pmRNSNotification Of Transactions By PDMR
16th Jan 20243:40 pmRNSDirector/PDMR Shareholding
15th Jan 20244:35 pmRNSHolding(s) in Company
12th Jan 20249:45 amRNSJoint Development Agreement with European Customer
22nd Dec 20237:00 amRNSAppointment of Financial Adviser and Joint Broker
21st Dec 202312:00 pmRNSAppointments of Non-Executive Directors
12th Dec 20239:35 amRNSBlocklisting six-monthly return
7th Dec 20233:23 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.